Article Versions Notes

Tsai T-H, Lee C-H, Cheng C-I, Fang Y-N, Chung S-Y, Chen S-M, Lin C-J, Wu C-J, Hang C-L, Chen W-Y. Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice. Cells. 2019; 8(6):589. https://doi.org/10.3390/cells8060589

Tsai, Tzu-Hsien, Chien-Ho Lee, Cheng-I Cheng, Yen-Nan Fang, Sheng-Ying Chung, Shyh-Ming Chen, Cheng-Jei Lin, Chiung-Jen Wu, Chi-Ling Hang, and Wei-Yu Chen. 2019. "Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice" Cells 8, no. 6: 589. https://doi.org/10.3390/cells8060589

Tsai, T. -H., Lee, C. -H., Cheng, C. -I., Fang, Y. -N., Chung, S. -Y., Chen, S. -M., Lin, C. -J., Wu, C. -J., Hang, C. -L., & Chen, W. -Y. (2019). Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice. Cells, 8(6), 589. https://doi.org/10.3390/cells8060589